Data & Analysis
Data & Analysis · page 7
- Data & Analysis
From Page to Platform: Prohibition Partners Unveils Interactive Cannabis Intelligence Hub
Prohibition Partners will soon be launching the 10th addition of their industry leading European Cannabis Report, marking the milestone with a ground-up overhaul of its tried and trusted format.
- Data & Analysis
UK Has Imported More Cannabis From Spain than Any Other Country Since 2021, New Figures Show
New data acquired from the Home Office by Prohibition Partners and Business of Cannabis shows that since 2021, the UK has imported the bulk of its medical cannabis from Spain.
- Data & Analysis
New Study Suggests Medical Cannabis Highly Cost-Effective Treatment for PTSD
Medical cannabis is a highly cost-effective treatment for individuals with moderate post-traumatic stress disorder (PTSD), according to a new study.
- Adult-Use
Illinois’ Cannabis Market Hits Record $2bn in Sales
Illinois’ cannabis industry hit $2 billion in total sales in 2024, generating $490 million in tax revenue, marking another year of growth since recreational cannabis was legalized in 2020.
- Data & Analysis
Australia’s Medical Cannabis Market Set to Outgrow Europe’s Biggest Players
According to Prohibition Partners’ new Global Cannabis Report: 5th Edition, launching today, Australia’s medical cannabis revenues are expected to grow from around US$600m in 2024 to more than US$1.2bn by 2028.
- Data & Analysis
Canadian Medical Cannabis Exports Doubled in First 6 Months of 2024
Canadian medical cannabis exports expanded dramatically in 2024 amid the rapid expansion of markets across Europe.
- Data & Analysis
Hundreds of UK Families Forced to Turn to Illicit Cannabis Market Due to Lack of NHS Access
This story was first reported on Cannabis Health News. Hundreds of families in the UK are giving their children illegal cannabis products due to a lack of access on the NHS, according to a new report.
- Opinion
Canexis Pharma: Setting the Standard for Purity in Medical Cannabis
Ahead of the release of Prohibition Partners upcoming Global Cannabis Report: 5th Edition, we sat down with Sebastian Zeller, Managing Director of Canexis Pharma AG, a Swiss-based leader in medical cannabis production.
- Press releases
SOMAÍ Pharmaceuticals Expands to Thailand With New PACCAN Partnership
SOMAÍ Pharmaceuticals, a leading EU-GMP vertically integrated Multi-Country Operator (MCO) with the most advanced cannabinoid pharmaceutical extract portfolio, has partnered with Pacific Cannovation Company Limited (PACCAN) to transform Thailand into a global hub for high-quality medicinal cannabis.
- Companies
Agrify Sells Cultivation Business, Focuses on THC Beverages with Señorita Brand
Agrify Corporation has completed the sale of its cultivation business to CP Acquisitions LLC, a company affiliated with Agrify’s former CEO, Raymond Chang.
- Adult-Use
US Cannabis Sales to Hit $32bn This Year as Industry Continues Record Growth
The US cannabis industry is experiencing rapid growth, with retail sales projected to exceed $32bn in 2024 and wholesale sales reaching nearly $12bn, according to a new study from Leaflink.
- Adult-Use
Cannabis Business Licenses Decline in 2024 Amid Regulatory Restructuring and Market Tightening
The number of active US cannabis business licenses – including those in regulated medical and recreational markets – continued to decline through the third quarter of 2024 as reductions in established markets outpaced growth in emerging ones.
